![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PRPF4 |
Gene summary for PRPF4 |
![]() |
Gene information | Species | Human | Gene symbol | PRPF4 | Gene ID | 9128 |
Gene name | pre-mRNA processing factor 4 | |
Gene Alias | HPRP4 | |
Cytomap | 9q32 | |
Gene Type | protein-coding | GO ID | GO:0000375 | UniProtAcc | O43172 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
9128 | PRPF4 | LZE2T | Human | Esophagus | ESCC | 6.88e-04 | 2.61e-01 | 0.082 |
9128 | PRPF4 | LZE4T | Human | Esophagus | ESCC | 9.84e-12 | 4.21e-01 | 0.0811 |
9128 | PRPF4 | LZE7T | Human | Esophagus | ESCC | 2.28e-08 | 4.77e-01 | 0.0667 |
9128 | PRPF4 | LZE8T | Human | Esophagus | ESCC | 1.71e-07 | 9.92e-02 | 0.067 |
9128 | PRPF4 | LZE20T | Human | Esophagus | ESCC | 4.18e-07 | 2.79e-01 | 0.0662 |
9128 | PRPF4 | LZE24T | Human | Esophagus | ESCC | 9.97e-10 | 2.35e-01 | 0.0596 |
9128 | PRPF4 | LZE21T | Human | Esophagus | ESCC | 3.33e-05 | 2.21e-01 | 0.0655 |
9128 | PRPF4 | P1T-E | Human | Esophagus | ESCC | 1.37e-12 | 3.30e-01 | 0.0875 |
9128 | PRPF4 | P2T-E | Human | Esophagus | ESCC | 1.61e-34 | 6.05e-01 | 0.1177 |
9128 | PRPF4 | P4T-E | Human | Esophagus | ESCC | 1.72e-21 | 4.89e-01 | 0.1323 |
9128 | PRPF4 | P5T-E | Human | Esophagus | ESCC | 5.92e-25 | 5.61e-01 | 0.1327 |
9128 | PRPF4 | P8T-E | Human | Esophagus | ESCC | 1.93e-12 | 1.43e-01 | 0.0889 |
9128 | PRPF4 | P9T-E | Human | Esophagus | ESCC | 1.35e-11 | 3.29e-01 | 0.1131 |
9128 | PRPF4 | P10T-E | Human | Esophagus | ESCC | 4.77e-36 | 7.65e-01 | 0.116 |
9128 | PRPF4 | P11T-E | Human | Esophagus | ESCC | 3.11e-03 | 3.52e-01 | 0.1426 |
9128 | PRPF4 | P12T-E | Human | Esophagus | ESCC | 2.41e-24 | 6.94e-01 | 0.1122 |
9128 | PRPF4 | P15T-E | Human | Esophagus | ESCC | 3.30e-31 | 1.04e+00 | 0.1149 |
9128 | PRPF4 | P16T-E | Human | Esophagus | ESCC | 1.51e-18 | 2.89e-01 | 0.1153 |
9128 | PRPF4 | P17T-E | Human | Esophagus | ESCC | 2.64e-02 | 3.28e-01 | 0.1278 |
9128 | PRPF4 | P20T-E | Human | Esophagus | ESCC | 2.99e-09 | 1.78e-01 | 0.1124 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00083809 | Breast | Precancer | RNA splicing | 65/1080 | 434/18723 | 1.27e-12 | 2.53e-10 | 65 |
GO:00003759 | Breast | Precancer | RNA splicing, via transesterification reactions | 52/1080 | 324/18723 | 1.74e-11 | 2.22e-09 | 52 |
GO:00003779 | Breast | Precancer | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 51/1080 | 320/18723 | 3.55e-11 | 4.04e-09 | 51 |
GO:00003989 | Breast | Precancer | mRNA splicing, via spliceosome | 51/1080 | 320/18723 | 3.55e-11 | 4.04e-09 | 51 |
GO:00226049 | Breast | Precancer | regulation of cell morphogenesis | 29/1080 | 309/18723 | 6.88e-03 | 4.67e-02 | 29 |
GO:000838014 | Breast | IDC | RNA splicing | 73/1434 | 434/18723 | 1.27e-10 | 1.57e-08 | 73 |
GO:000037514 | Breast | IDC | RNA splicing, via transesterification reactions | 58/1434 | 324/18723 | 9.44e-10 | 9.58e-08 | 58 |
GO:000037714 | Breast | IDC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 57/1434 | 320/18723 | 1.60e-09 | 1.49e-07 | 57 |
GO:000039814 | Breast | IDC | mRNA splicing, via spliceosome | 57/1434 | 320/18723 | 1.60e-09 | 1.49e-07 | 57 |
GO:000838024 | Breast | DCIS | RNA splicing | 73/1390 | 434/18723 | 3.05e-11 | 5.08e-09 | 73 |
GO:000037524 | Breast | DCIS | RNA splicing, via transesterification reactions | 58/1390 | 324/18723 | 2.89e-10 | 3.34e-08 | 58 |
GO:000037724 | Breast | DCIS | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 57/1390 | 320/18723 | 5.01e-10 | 5.35e-08 | 57 |
GO:000039824 | Breast | DCIS | mRNA splicing, via spliceosome | 57/1390 | 320/18723 | 5.01e-10 | 5.35e-08 | 57 |
GO:000838010 | Cervix | CC | RNA splicing | 76/2311 | 434/18723 | 9.79e-04 | 8.19e-03 | 76 |
GO:000037710 | Cervix | CC | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 55/2311 | 320/18723 | 6.71e-03 | 3.70e-02 | 55 |
GO:000039810 | Cervix | CC | mRNA splicing, via spliceosome | 55/2311 | 320/18723 | 6.71e-03 | 3.70e-02 | 55 |
GO:000037510 | Cervix | CC | RNA splicing, via transesterification reactions | 55/2311 | 324/18723 | 8.61e-03 | 4.44e-02 | 55 |
GO:0008380 | Colorectum | AD | RNA splicing | 169/3918 | 434/18723 | 3.59e-18 | 2.04e-15 | 169 |
GO:0000377 | Colorectum | AD | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 130/3918 | 320/18723 | 5.88e-16 | 2.16e-13 | 130 |
GO:0000398 | Colorectum | AD | mRNA splicing, via spliceosome | 130/3918 | 320/18723 | 5.88e-16 | 2.16e-13 | 130 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0304027 | Esophagus | ESCC | Spliceosome | 128/4205 | 217/8465 | 3.31e-03 | 8.79e-03 | 4.50e-03 | 128 |
hsa0304037 | Esophagus | ESCC | Spliceosome | 128/4205 | 217/8465 | 3.31e-03 | 8.79e-03 | 4.50e-03 | 128 |
hsa0304022 | Liver | HCC | Spliceosome | 122/4020 | 217/8465 | 5.55e-03 | 1.60e-02 | 8.91e-03 | 122 |
hsa0304032 | Liver | HCC | Spliceosome | 122/4020 | 217/8465 | 5.55e-03 | 1.60e-02 | 8.91e-03 | 122 |
hsa0304016 | Oral cavity | OSCC | Spliceosome | 123/3704 | 217/8465 | 7.21e-05 | 2.74e-04 | 1.40e-04 | 123 |
hsa0304017 | Oral cavity | OSCC | Spliceosome | 123/3704 | 217/8465 | 7.21e-05 | 2.74e-04 | 1.40e-04 | 123 |
hsa0304026 | Oral cavity | LP | Spliceosome | 106/2418 | 217/8465 | 1.30e-10 | 2.40e-09 | 1.55e-09 | 106 |
hsa0304036 | Oral cavity | LP | Spliceosome | 106/2418 | 217/8465 | 1.30e-10 | 2.40e-09 | 1.55e-09 | 106 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PRPF4 | SNV | Missense_Mutation | novel | c.313N>A | p.Asp105Asn | p.D105N | O43172 | protein_coding | tolerated(0.06) | possibly_damaging(0.52) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
PRPF4 | SNV | Missense_Mutation | c.670N>G | p.Phe224Val | p.F224V | O43172 | protein_coding | tolerated(0.2) | benign(0.03) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD | |
PRPF4 | SNV | Missense_Mutation | c.146G>T | p.Gly49Val | p.G49V | O43172 | protein_coding | deleterious(0.02) | benign(0) | TCGA-B5-A0K2-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Hormone Therapy | megace | SD | |
PRPF4 | SNV | Missense_Mutation | novel | c.242N>C | p.Glu81Ala | p.E81A | O43172 | protein_coding | tolerated(0.28) | benign(0.021) | TCGA-B5-A1MR-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
PRPF4 | SNV | Missense_Mutation | novel | c.1466N>G | p.Ala489Gly | p.A489G | O43172 | protein_coding | tolerated(0.11) | possibly_damaging(0.472) | TCGA-BK-A13B-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
PRPF4 | SNV | Missense_Mutation | c.884N>G | p.Asn295Ser | p.N295S | O43172 | protein_coding | tolerated(0.39) | benign(0.026) | TCGA-DI-A1BU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Chemotherapy | paclitaxel | SD | |
PRPF4 | SNV | Missense_Mutation | novel | c.1516N>T | p.Leu506Phe | p.L506F | O43172 | protein_coding | tolerated(0.46) | benign(0.007) | TCGA-EO-A22U-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PRPF4 | SNV | Missense_Mutation | c.1245N>A | p.Phe415Leu | p.F415L | O43172 | protein_coding | deleterious(0.01) | probably_damaging(0.91) | TCGA-EO-A3AV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | CR | |
PRPF4 | SNV | Missense_Mutation | c.373G>T | p.Gly125Cys | p.G125C | O43172 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-49-6744-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Chemotherapy | unknown | SD | |
PRPF4 | SNV | Missense_Mutation | c.502N>T | p.His168Tyr | p.H168Y | O43172 | protein_coding | deleterious(0) | possibly_damaging(0.873) | TCGA-4B-A93V-01 | Lung | lung adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |